
Erlomy 100mg Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Erlotinib (100mg)
Overview Erlomy 100mg Tablet
Erlomy 100mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow prescribed dosage precisely; incorrect use or overdose may cause serious adverse effects. Benefits may take weeks or months to appear; do not discontinue without your doctor's instruction. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical consultation. Photosensitivity necessitates sun protection. Report mouth sores, vision changes, or breathing problems immediately. Liver function monitoring may be required. Inform your healthcare provider of all other medications, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners. Smoking cessation is advised, as it can interfere with treatment efficacy. Maintain a two-hour interval between Erlomys and antacids or other medications.
Primary Ingredients of Erlomy 100mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Erlomy 100mg Tablet
Cancers of the pancreas and non-small cell lung
Major Benefits of Erlomy 100mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 100mg Erlomy tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Erlomy 100mg Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlomy 100mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 100mg Erlomy tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Erlomy 100mg Tablet works:
Erlomy 100mg tablets are an anti-cancer drug targeting lung cancer cells. These cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The medication functions by attaching to these EGFRs, thereby blocking the EGFR-driven cancer cell signaling cascades and halting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Erlomy 100mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Erlommy 100mg tablets during pregnancy carries a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Erlomys 100mg tablets. Preliminary evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Erlomy 100mg Tablet's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Erlomy 100mg tablets are considered safe for individuals with kidney impairment; no dosage modification is necessary. However, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Erlomy 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erlomy 100mg Tablet :
Omit any missed Erlomy 100mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Erlomy 100mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline-based compound |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
